These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30674072)

  • 1. Systemic comorbidities are associated with medication-related osteonecrosis of the jaws: Case-control study.
    McGowan K; Acton C; Ivanovski S; Johnson NW; Ware RS
    Oral Dis; 2019 May; 25(4):1107-1115. PubMed ID: 30674072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Both non-surgical dental treatment and extractions increase the risk of medication-related osteonecrosis of the jaw: case-control study.
    McGowan K; Ware RS; Acton C; Ivanovski S; Johnson NW
    Clin Oral Investig; 2019 Nov; 23(11):3967-3975. PubMed ID: 30747305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Full blood counts are not predictive of the risk of medication-related osteonecrosis of the jaws: a case-control study.
    McGowan K; Ware RS; Acton C; Ivanovski S; Johnson NW
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2019 Oct; 128(4):373-380. PubMed ID: 31097394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiographic bone loss and the risk of medication-related osteonecrosis of the jaw (MRONJ) in multiple myeloma patients-A retrospective case control study.
    Wazzan T; Kashtwari D; Almaden WF; Gong Y; Chen Y; Moreb J; Katz J
    Spec Care Dentist; 2018 Nov; 38(6):356-361. PubMed ID: 30194738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.
    Ghidini G; Manfredi M; Giovannacci I; Mergoni G; Sarraj A; Mureddu M; Giunta G; Bonanini M; Meleti M; Vescovi P
    Minerva Stomatol; 2017 Aug; 66(4):135-140. PubMed ID: 28497661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteonecrosis of the jaws: a 14-year retrospective survey of hospital admissions.
    McGowan K; Ivanovski S; Acton C
    Aust Dent J; 2018 Jun; 63(2):202-207. PubMed ID: 29432652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pain characteristics in medication-related osteonecrosis of the jaws.
    Haviv Y; Geller Z; Mazor S; Sharav Y; Keshet N; Zadik Y
    Support Care Cancer; 2021 Feb; 29(2):1073-1080. PubMed ID: 32601851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Position paper on medication-related osteonecrosis of the jaw (MRONJ)].
    Svejda B; Muschitz Ch; Gruber R; Brandtner Ch; Svejda Ch; Gasser RW; Santler G; Dimai HP
    Wien Med Wochenschr; 2016 Feb; 166(1-2):68-74. PubMed ID: 26847441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the prevalence of the medication-related osteonecrosis of the jaws underestimated, evaluation in oncological and non-oncological disease.
    Galis B; Zajko J; Hirjak D; Vanko L; Kupcova I; Jurkemik J; Gengelova P; Mikuskova K; Halmova K; Riznic M; Czako L
    Bratisl Lek Listy; 2017; 118(12):724-731. PubMed ID: 29322803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication--related osteonecrosis of the jaws. The first reported cases in the Baltic States and a literature review.
    Zaleckas L; Stacevičius M; Proškutė D; Povilaitytė J
    Stomatologija; 2015; 17(3):89-96. PubMed ID: 26879401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Declining Incidence of Medication-Related Osteonecrosis of the Jaw in Patients With Cancer.
    Sim IeW; Sanders KM; Borromeo GL; Seymour JF; Ebeling PR
    J Clin Endocrinol Metab; 2015 Oct; 100(10):3887-93. PubMed ID: 26241323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dental implants as risk factors for patients with medication-related osteonecrosis of the jaws (MRONJ).
    Pichardo SEC; van der Hee JG; Fiocco M; Appelman-Dijkstra NM; van Merkesteyn JPR
    Br J Oral Maxillofac Surg; 2020 Sep; 58(7):771-776. PubMed ID: 32631756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.
    Baba A; Goto TK; Ojiri H; Takagiwa M; Hiraga C; Okamura M; Hasegawa S; Okuyama Y; Ogino N; Yamauchi H; Kobashi Y; Yamazoe S; Munetomo Y; Mogami T; Nomura T
    Dentomaxillofac Radiol; 2018 May; 47(4):20170323. PubMed ID: 29365278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A population based study of multiple myeloma patients with medication-related osteonecrosis of the jaw.
    Auzina D; Slaidina A; Sevastjanova M; Erts R; Lejnieks A; Lejniece S
    Stomatologija; 2019; 21(1):13-17. PubMed ID: 31619658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Prevention of Medication-related Osteonecrosis of the Jaw.
    Poxleitner P; Engelhardt M; Schmelzeisen R; Voss P
    Dtsch Arztebl Int; 2017 Feb; 114(5):63-69. PubMed ID: 28241916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of healing impairment following tooth extraction in patients administered with antiresorptive and non-antiresorptive polypharmacy.
    Suryani IR; Shujaat S; Ivković U; Coucke W; Coropciuc R; Jacobs R
    J Stomatol Oral Maxillofac Surg; 2024 Apr; 125(2):101645. PubMed ID: 37748709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What is the effect of anti-resorptive drugs (ARDs) on the development of medication-related osteonecrosis of the jaw (MRONJ) in osteoporosis patients: A systematic review.
    Aljohani S; Fliefel R; Ihbe J; Kühnisch J; Ehrenfeld M; Otto S
    J Craniomaxillofac Surg; 2017 Sep; 45(9):1493-1502. PubMed ID: 28687467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Frequency of Medication-related Osteonecrosis of the Jaw and its Associated Risk Factors.
    Dodson TB
    Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):509-16. PubMed ID: 26362367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-Sectional Study of four Serological Bone Turnover Markers for the Risk Assessment of Medication-Related Osteonecrosis of the Jaw.
    Peisker A; Raschke GF; Fahmy MD; Guentsch A; Roshanghias K; König KC; Schultze-Mosgau S
    J Craniofac Surg; 2018 Mar; 29(2):e137-e140. PubMed ID: 29215447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug holiday clinical relevance verification for antiresorptive agents in medication-related osteonecrosis cases of the jaw.
    Hayashida S; Yanamoto S; Fujita S; Hasegawa T; Komori T; Kojima Y; Miyamoto H; Shibuya Y; Ueda N; Kirita T; Nakahara H; Shinohara M; Kondo E; Kurita H; Umeda M
    J Bone Miner Metab; 2020 Jan; 38(1):126-134. PubMed ID: 31410544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.